Central Washington Hospital Homecare Services 1300 Fuller Street, Wenatchee, WA, 98801 | |
(509) 665-6049 |
News Archive
BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).
The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.
Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.
Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.
› Verified 9 days ago
Name | Central Washington Hospital Homecare Services |
---|---|
Location | 1300 Fuller Street, Wenatchee, Washington |
Hospice ID | 501516 |
Category | Part of a hospital |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
SSA county code | 030 |
News Archive
BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).
The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.
Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.
Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.
› Verified 9 days ago
NPI Number | 1508978388 |
Organization Name | Central Washington Health Services Association |
Address | 1020 N Wenatchee Ave Wenatchee, Washington, 98801 |
Phone Number | (509)665-6049 |
News Archive
BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).
The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.
Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.
Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.
› Verified 9 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.6 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.6 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 99.1 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.8 | 97.3 |
Patients who got timely treatment for shortness of breath | 98.8 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 97.2 | 93.3 |
News Archive
BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).
The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.
Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.
Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.
› Verified 9 days ago
Home Health Aides | 4 |
Counselors | 1.5 |
Medical Social Workers | 4.5 |
Physicians | 0.25 |
Registered Nurses | 11.1 |
Other Personnel | 2.5 |
Total Employees | 23.85 |
---|
News Archive
BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).
The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.
Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.
Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.
› Verified 9 days ago
Others | 29 |
Total Volunteers | 29 |
---|
News Archive
BioSante Pharmaceuticals, Inc., a pharmaceutical company developing products for the treatment of female sexual health, today announced results of a survey of over 100 Obstetrician/Gynecologists and Primary Care Physicians regarding the need for an FDA-approved drug to treat a form of Female Sexual Dysfunction (FSD) known as Hypoactive Sexual Desire Disorder (HSDD).
The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.
Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.
Telestroke networks that enable the remote and rapid diagnosis and treatment of stroke can improve the bottom line of patients and hospitals, researchers report.
› Verified 9 days ago
Central Washington Hospital Homecare Services Location: 1300 Fuller Street, Wenatchee, Washington, 98801 Phone: (509) 665-6049 |